Litcius/Paper detail

New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with <i>in silico</i> docking, ADMET, toxicity, and DFT studies

Mohammed M. Alanazi, Hazem Elkady, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Manal M. Alanazi, Madhawi A. Alharbi, Ibrahim H. Eissa, Mohammed A. Dahab

2021RSC Advances68 citationsDOIOpen Access PDF

Abstract

ADMET, toxicity, and physico-chemical properties revealed that most of the synthesized members have acceptable values of drug-likeness. Finally, DFT studies were carried out to calculate the thermodynamic, molecular orbital and electrostatic potential properties.

Topics & Concepts

In silicoDocking (animal)ChemistryVEGF receptorsQuinoxalineCombinatorial chemistryToxicityPharmacologyComputational biologyStereochemistryBiochemistryOrganic chemistryBiologyCancer researchMedicineNursingGeneSynthesis and Biological EvaluationSynthesis and Reactions of Organic CompoundsChemotherapy-induced cardiotoxicity and mitigation
New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with <i>in silico</i> docking, ADMET, toxicity, and DFT studies | Litcius